{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:42:39Z","timestamp":1793392959236,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59626-0","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T06:42:39Z","timestamp":1747550559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset"],"prefix":"10.1038","volume":"16","author":[{"given":"Gregory J.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-6925","authenticated-orcid":false,"given":"Jacob T.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Amses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2090-0877","authenticated-orcid":false,"given":"Melanie R.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sada Japp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9812-1676","authenticated-orcid":false,"given":"Chengyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6665-4865","authenticated-orcid":false,"given":"M. Betina","family":"Pampena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Kuri-Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HPAP Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2878-9296","authenticated-orcid":false,"given":"Todd M.","family":"Brusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-9211","authenticated-orcid":false,"given":"Eline T.","family":"Luning Prak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1228-021X","authenticated-orcid":false,"given":"Klaus H.","family":"Kaestner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7690-1484","authenticated-orcid":false,"given":"Michael R.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,18]]},"reference":[{"key":"59626_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69\u201382 (2014).","journal-title":"Lancet"},{"key":"59626_CR2","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel, R. A. et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diab. Care 38, 1964\u20131974 (2015).","journal-title":"Diab. Care"},{"key":"59626_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2337\/dc14-0871","volume":"38","author":"RA Oram","year":"2015","unstructured":"Oram, R. A. et al. Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors. Diab. Care 38, 323\u2013328 (2015).","journal-title":"Diab. Care"},{"key":"59626_CR4","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00125-016-4087-0","volume":"59","author":"GM Williams","year":"2016","unstructured":"Williams, G. M. et al. Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes. Diabetologia 59, 2722\u20132726 (2016).","journal-title":"Diabetologia"},{"key":"59626_CR5","doi-asserted-by":"crossref","unstructured":"Gubitosi-Klug, R. A. et al. Residual \u03b2 cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia. J. Clin. Invest. 131, e143011 (2021).","DOI":"10.1172\/JCI143011"},{"key":"59626_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ng2068","volume":"39","author":"JA Todd","year":"2007","unstructured":"Todd, J. A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857\u2013864 (2007).","journal-title":"Nat. Genet."},{"key":"59626_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature06406","volume":"450","author":"S Nejentsev","year":"2007","unstructured":"Nejentsev, S. et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450, 887\u2013892 (2007).","journal-title":"Nature"},{"key":"59626_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/imcb.12438","volume":"99","author":"MR Shapiro","year":"2021","unstructured":"Shapiro, M. R. et al. De-coding genetic risk variants in type 1 diabetes. Immunol. Cell Biol. 99, 496\u2013508 (2021).","journal-title":"Immunol. Cell Biol."},{"key":"59626_CR9","doi-asserted-by":"crossref","unstructured":"Sims, E. K. et al. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci. Transl. Med. 13, eabc8980 (2021).","DOI":"10.1126\/scitranslmed.abc8980"},{"key":"59626_CR10","doi-asserted-by":"publisher","first-page":"eaai7793","DOI":"10.1126\/sciimmunol.aai7793","volume":"1","author":"SA Long","year":"2016","unstructured":"Long, S. A. et al. Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes. Sci. Immunol. 1, eaai7793 (2016).","journal-title":"Sci. Immunol."},{"key":"59626_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1172\/JCI76238","volume":"125","author":"R Kenefeck","year":"2015","unstructured":"Kenefeck, R. et al. Follicular helper T cell signature in type 1 diabetes. J. Clin. Invest. 125, 292\u2013303 (2015).","journal-title":"J. Clin. Invest."},{"key":"59626_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41590-020-0633-5","volume":"21","author":"HA Abdelsamed","year":"2020","unstructured":"Abdelsamed, H. A. et al. Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes. Nat. Immunol. 21, 578\u2013587 (2020).","journal-title":"Nat. Immunol."},{"key":"59626_CR13","doi-asserted-by":"crossref","unstructured":"Pesenacker, A. M. et al. Treg gene signatures predict and measure type 1 diabetes trajectory. JCI Insight 4, e123879 (2019).","DOI":"10.1172\/jci.insight.123879"},{"key":"59626_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.clim.2017.09.021","volume":"183","author":"P Hanley","year":"2017","unstructured":"Hanley, P. et al. Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes. Clin. Immunol. 183, 336\u2013343 (2017).","journal-title":"Clin. Immunol."},{"key":"59626_CR15","doi-asserted-by":"crossref","unstructured":"Stensland, Z. C. et al. Identification of an anergic BND cell-derived activated B cell population (BND2) in young-onset type 1 diabetes patients. J. Exp. Med. 220, e20221604 (2023).","DOI":"10.1084\/jem.20221604"},{"key":"59626_CR16","doi-asserted-by":"crossref","unstructured":"Xhonneux, L.-P. et al. Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression. Sci. Transl. Med. 13, eabd5666 (2021).","DOI":"10.1126\/scitranslmed.abd5666"},{"key":"59626_CR17","doi-asserted-by":"crossref","unstructured":"Shapiro, M. R. et al. Human immune phenotyping reveals accelerated aging in type 1 diabetes. JCI Insight 8, e170767 (2023).","DOI":"10.1172\/jci.insight.170767"},{"key":"59626_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41590-022-01395-9","volume":"24","author":"MML Poon","year":"2023","unstructured":"Poon, M. M. L. et al. Tissue adaptation and clonal segregation of human memory T cells in barrier sites. Nat. Immunol. 24, 309\u2013319 (2023).","journal-title":"Nat. Immunol."},{"key":"59626_CR19","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.cell.2020.11.019","volume":"183","author":"M Buggert","year":"2020","unstructured":"Buggert, M. et al. The identity of human tissue-emigrant CD8+ T cells. Cell 183, 1946\u20131961.e15 (2020).","journal-title":"Cell"},{"key":"59626_CR20","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41590-023-01538-6","volume":"24","author":"M Buggert","year":"2023","unstructured":"Buggert, M., Price, D. A., Mackay, L. K. & Betts, M. R. Human circulating and tissue-resident memory CD8+ T cells. Nat. Immunol. 24, 1076\u20131086 (2023).","journal-title":"Nat. Immunol."},{"key":"59626_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya, M., Kwak, K. & Pierce, S. K. B cell memory: building two walls of protection against pathogens. Nat. Rev. Immunol. 20, 229\u2013238 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"59626_CR22","doi-asserted-by":"crossref","unstructured":"Hashemi, E. & Malarkannan, S. Tissue-resident NK cells: development, maturation, and clinical relevance. Cancers 12, 1553 (2020).","DOI":"10.3390\/cancers12061553"},{"key":"59626_CR23","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/nm.4203","volume":"22","author":"JAB Babon","year":"2016","unstructured":"Babon, J. A. B. et al. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat. Med. 22, 1482\u20131487 (2016).","journal-title":"Nat. Med."},{"key":"59626_CR24","doi-asserted-by":"crossref","unstructured":"Culina, S. et al. Islet-reactive CD8 + T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci. Immunol. 3, eaao4013 (2018).","DOI":"10.1126\/sciimmunol.aao4013"},{"key":"59626_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.5.4.397","volume":"5","author":"EL Opie","year":"1901","unstructured":"Opie, E. L. On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes melutus. J. Exp. Med. 5, 397\u2013428 (1901).","journal-title":"J. Exp. Med."},{"key":"59626_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","volume":"209","author":"KT Coppieters","year":"2012","unstructured":"Coppieters, K. T. et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 209, 51\u201360 (2012).","journal-title":"J. Exp. Med."},{"key":"59626_CR27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete, P. et al. Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes. Diabetes 65, 1362\u20131369 (2016).","journal-title":"Diabetes"},{"key":"59626_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson, M. et al. Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes. Diabetes 65, 719\u2013731 (2016).","journal-title":"Diabetes"},{"key":"59626_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cmet.2019.01.003","volume":"29","author":"YJ Wang","year":"2019","unstructured":"Wang, Y. J. et al. Multiplexed in situ imaging mass cytometry analysis of the human endocrine pancreas and immune system in type 1 diabetes. Cell Metab. 29, 769\u2013783.e4 (2019).","journal-title":"Cell Metab."},{"key":"59626_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","volume":"29","author":"N Damond","year":"2019","unstructured":"Damond, N. et al. A map of human type 1 diabetes progression by imaging mass cytometry. Cell Metab. 29, 755\u2013768.e5 (2019).","journal-title":"Cell Metab."},{"key":"59626_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1084\/jem.20011353","volume":"196","author":"M-C Gagnerault","year":"2002","unstructured":"Gagnerault, M.-C., Luan, J. J., Lotton, C. & Lepault, F. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196, 369\u2013377 (2002).","journal-title":"J. Exp. Med."},{"key":"59626_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature03625","volume":"435","author":"SC Kent","year":"2005","unstructured":"Kent, S. C. et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435, 224\u2013228 (2005).","journal-title":"Nature"},{"key":"59626_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88242","volume":"1","author":"HR Seay","year":"2016","unstructured":"Seay, H. R. et al. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes. JCI Insight 1, e88242 (2016).","journal-title":"JCI Insight"},{"key":"59626_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","volume":"602","author":"SV Gearty","year":"2022","unstructured":"Gearty, S. V. et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature 602, 156\u2013161 (2022).","journal-title":"Nature"},{"key":"59626_CR35","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.2337\/db11-0090","volume":"60","author":"A Ferraro","year":"2011","unstructured":"Ferraro, A. et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60, 2903\u20132913 (2011).","journal-title":"Diabetes"},{"key":"59626_CR36","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.2337\/db21-0091","volume":"70","author":"A Vecchione","year":"2021","unstructured":"Vecchione, A. et al. Reduced follicular regulatory T cells in spleen and pancreatic lymph nodes of patients with type 1 diabetes. Diabetes 70, 2892\u20132902 (2021).","journal-title":"Diabetes"},{"key":"59626_CR37","doi-asserted-by":"crossref","unstructured":"Kaestner, K. H., Powers, A. C., Naji, A., HPAP Consortium & Atkinson, M. A. NIH initiative to improve understanding of the pancreas, islet, and autoimmunity in type 1 diabetes: the Human Pancreas Analysis Program (HPAP). Diabetes 68, 1394\u20131402 (2019).","DOI":"10.2337\/db19-0058"},{"key":"59626_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-065X.2008.00757.x","volume":"228","author":"JA Readinger","year":"2009","unstructured":"Readinger, J. A., Mueller, K. L., Venegas, A. M., Horai, R. & Schwartzberg, P. L. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk\/Txk. Immunol. Rev. 228, 93\u2013114 (2009).","journal-title":"Immunol. Rev."},{"key":"59626_CR39","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.4049\/jimmunol.168.5.2365","volume":"168","author":"Y Takeba","year":"2002","unstructured":"Takeba, Y., Nagafuchi, H., Takeno, M., Kashiwakura, J.-I. & Suzuki, N. Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription. J. Immunol. 168, 2365\u20132370 (2002).","journal-title":"J. Immunol."},{"key":"59626_CR40","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00262-018-2165-5","volume":"67","author":"J Kos","year":"2018","unstructured":"Kos, J. et al. Cystatin F as a regulator of immune cell cytotoxicity. Cancer Immunol. Immunother. 67, 1931\u20131938 (2018).","journal-title":"Cancer Immunol. Immunother."},{"key":"59626_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nri2958","volume":"11","author":"JJ O\u2019Shea","year":"2011","unstructured":"O\u2019Shea, J. J., Lahesmaa, R., Vahedi, G., Laurence, A. & Kanno, Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat. Rev. Immunol. 11, 239\u2013250 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"59626_CR42","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/MCB.00331-06","volume":"26","author":"S Kliche","year":"2006","unstructured":"Kliche, S. et al. The ADAP\/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1. Mol. Cell. Biol. 26, 7130\u20137144 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"59626_CR43","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3389\/fimmu.2018.02113","volume":"9","author":"AP Ferretti","year":"2018","unstructured":"Ferretti, A. P., Bhargava, R., Dahan, S., Tsokos, M. G. & Tsokos, G. C. Calcium\/calmodulin kinase IV controls the function of both T cells and kidney resident cells. Front. Immunol. 9, 2113 (2018).","journal-title":"Front. Immunol."},{"key":"59626_CR44","doi-asserted-by":"publisher","first-page":"ra84","DOI":"10.1126\/scisignal.2002058","volume":"4","author":"G Fu","year":"2011","unstructured":"Fu, G. et al. Protein kinase C \u03b7 is required for T cell activation and homeostatic proliferation. Sci. Signal 4, ra84 (2011).","journal-title":"Sci. Signal"},{"key":"59626_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/429843","volume":"76","author":"A Vella","year":"2005","unstructured":"Vella, A. et al. Localization of a type 1 diabetes locus in the IL2RA\/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76, 773\u2013779 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"59626_CR46","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1084\/jem.20100209","volume":"207","author":"Y Grinberg-Bleyer","year":"2010","unstructured":"Grinberg-Bleyer, Y. et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207, 1871\u20131878 (2010).","journal-title":"J. Exp. Med."},{"key":"59626_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","volume":"30","author":"N Ohkura","year":"2020","unstructured":"Ohkura, N. & Sakaguchi, S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res. 30, 465\u2013474 (2020).","journal-title":"Cell Res."},{"key":"59626_CR48","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3389\/fimmu.2019.03100","volume":"10","author":"D Shevyrev","year":"2019","unstructured":"Shevyrev, D. & Tereshchenko, V. Treg heterogeneity, function, and homeostasis. Front. Immunol. 10, 3100 (2019).","journal-title":"Front. Immunol."},{"key":"59626_CR49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1086\/378781","volume":"73","author":"O Dowling","year":"2003","unstructured":"Dowling, O. et al. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am. J. Hum. Genet. 73, 957\u2013966 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"59626_CR50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature17947","volume":"533","author":"J Li","year":"2016","unstructured":"Li, J., Lu, E., Yi, T. & Cyster, J. G. EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells. Nature 533, 110\u2013114 (2016).","journal-title":"Nature"},{"key":"59626_CR51","doi-asserted-by":"publisher","first-page":"50612","DOI":"10.1074\/jbc.M209529200","volume":"277","author":"S-E Lin","year":"2002","unstructured":"Lin, S.-E., Oyama, T., Nagase, T., Harigaya, K. & Kitagawa, M. Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling. J. Biol. Chem. 277, 50612\u201350620 (2002).","journal-title":"J. Biol. Chem."},{"key":"59626_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07018-y","volume":"9","author":"S Ghosh","year":"2018","unstructured":"Ghosh, S., Roy-Chowdhuri, S., Kang, K., Im, S.-H. & Rudra, D. The transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cells. Nat. Commun. 9, 4473 (2018).","journal-title":"Nat. Commun."},{"key":"59626_CR53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature05673","volume":"446","author":"M Ono","year":"2007","unstructured":"Ono, M. et al. Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1. Nature 446, 685\u2013689 (2007).","journal-title":"Nature"},{"key":"59626_CR54","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s42255-021-00356-0","volume":"3","author":"K Han","year":"2021","unstructured":"Han, K. et al. Fasting-induced FOXO4 blunts human CD4+ T helper cell responsiveness. Nat. Metab. 3, 318\u2013326 (2021).","journal-title":"Nat. Metab."},{"key":"59626_CR55","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1073\/pnas.0611222104","volume":"104","author":"MS Vacchio","year":"2007","unstructured":"Vacchio, M. S., Olaru, A., Livak, F. & Hodes, R. J. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor \u03b1 locus coding end breaks. Proc. Natl Acad. Sci. USA 104, 6323\u20136328 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59626_CR56","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 in T cell function. Exp. Cell Res. 317, 620\u2013631 (2011).","journal-title":"Exp. Cell Res."},{"key":"59626_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ni.3441","volume":"17","author":"R Roychoudhuri","year":"2016","unstructured":"Roychoudhuri, R. et al. BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers. Nat. Immunol. 17, 851\u2013860 (2016).","journal-title":"Nat. Immunol."},{"key":"59626_CR58","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41590-021-00868-7","volume":"22","author":"C Yao","year":"2021","unstructured":"Yao, C. et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat. Immunol. 22, 370\u2013380 (2021).","journal-title":"Nat. Immunol."},{"key":"59626_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"59626_CR60","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"59626_CR61","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"59626_CR62","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1182\/blood-2006-07-036210","volume":"110","author":"M-L Boulland","year":"2007","unstructured":"Boulland, M.-L. et al. Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood 110, 220\u2013227 (2007).","journal-title":"Blood"},{"key":"59626_CR63","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2337\/db10-0076","volume":"59","author":"F Pociot","year":"2010","unstructured":"Pociot, F. et al. Genetics of type 1 diabetes: what\u2019s next? Diabetes 59, 1561\u20131571 (2010).","journal-title":"Diabetes"},{"key":"59626_CR64","doi-asserted-by":"publisher","first-page":"a007732","DOI":"10.1101\/cshperspect.a007732","volume":"2","author":"JA Noble","year":"2012","unstructured":"Noble, J. A. & Erlich, H. A. Genetics of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2, a007732 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"59626_CR65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","volume":"11","author":"JA Noble","year":"2011","unstructured":"Noble, J. A. & Valdes, A. M. Genetics of the HLA region in the prediction of type 1 diabetes. Curr. Diab Rep. 11, 533\u2013542 (2011).","journal-title":"Curr. Diab Rep."},{"key":"59626_CR66","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s00125-020-05276-4","volume":"63","author":"MB Johnson","year":"2020","unstructured":"Johnson, M. B. et al. Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells. Diabetologia 63, 2605\u20132615 (2020).","journal-title":"Diabetologia"},{"key":"59626_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/dc15-1111","volume":"39","author":"RA Oram","year":"2016","unstructured":"Oram, R. A. et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diab. Care 39, 337\u2013344 (2016).","journal-title":"Diab. Care"},{"key":"59626_CR68","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2337\/dc18-1785","volume":"42","author":"SA Sharp","year":"2019","unstructured":"Sharp, S. A. et al. Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diab. Care 42, 200\u2013207 (2019).","journal-title":"Diab. Care"},{"key":"59626_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0090-1229(88)90094-3","volume":"49","author":"MG Roncarolo","year":"1988","unstructured":"Roncarolo, M. G. et al. Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes. Clin. Immunol. Immunopathol. 49, 53\u201362 (1988).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"59626_CR70","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s001250050135","volume":"37","author":"T Tomoda","year":"1994","unstructured":"Tomoda, T., Kurashige, T. & Taniguchi, T. Imbalance of the interleukin 2 system in children with IDDM. Diabetologia 37, 476\u2013482 (1994).","journal-title":"Diabetologia"},{"key":"59626_CR71","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri1435","volume":"4","author":"TR Malek","year":"2004","unstructured":"Malek, T. R. & Bayer, A. L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4, 665\u2013674 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"59626_CR72","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3389\/fimmu.2018.02987","volume":"9","author":"V Kalia","year":"2018","unstructured":"Kalia, V. & Sarkar, S. Regulation of effector and memory CD8 T cell differentiation by IL-2-A balancing act. Front. Immunol. 9, 2987 (2018).","journal-title":"Front. Immunol."},{"key":"59626_CR73","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41590-024-01860-7","volume":"25","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans. Nat. Immunol. 25, 1231\u20131244 (2024).","journal-title":"Nat. Immunol."},{"key":"59626_CR74","doi-asserted-by":"crossref","unstructured":"Sekine, T. et al. TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells. Sci. Immunol. 5, eaba7918 (2020).","DOI":"10.1126\/sciimmunol.aba7918"},{"key":"59626_CR75","doi-asserted-by":"publisher","first-page":"eabi9591","DOI":"10.1126\/science.abi9591","volume":"376","author":"J Li","year":"2022","unstructured":"Li, J. et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 376, eabi9591 (2022).","journal-title":"Science"},{"key":"59626_CR76","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1172\/JCI200421307","volume":"114","author":"P Achenbach","year":"2004","unstructured":"Achenbach, P. et al. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J. Clin. Invest. 114, 589\u2013597 (2004).","journal-title":"J. Clin. Invest."},{"key":"59626_CR77","doi-asserted-by":"publisher","first-page":"108928","DOI":"10.1016\/j.clim.2022.108928","volume":"235","author":"M Hoffmann","year":"2022","unstructured":"Hoffmann, M. et al. Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes\u2014impact of IL7RA polymorphisms, HLA risk genotypes and clinical features. Clin. Immunol. 235, 108928 (2022).","journal-title":"Clin. Immunol."},{"key":"59626_CR78","doi-asserted-by":"publisher","first-page":"1157265","DOI":"10.3389\/fimmu.2023.1157265","volume":"14","author":"A-M Schroderus","year":"2023","unstructured":"Schroderus, A.-M. et al. Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression. Front. Immunol. 14, 1157265 (2023).","journal-title":"Front. Immunol."},{"key":"59626_CR79","doi-asserted-by":"publisher","first-page":"12674","DOI":"10.1073\/pnas.1203795109","volume":"109","author":"L-F Lee","year":"2012","unstructured":"Lee, L.-F. et al. Anti-IL-7 receptor-\u03b1 reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proc. Natl Acad. Sci. USA 109, 12674\u201312679 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59626_CR80","doi-asserted-by":"publisher","first-page":"12668","DOI":"10.1073\/pnas.1203692109","volume":"109","author":"C Penaranda","year":"2012","unstructured":"Penaranda, C. et al. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector\/memory T cells. Proc. Natl Acad. Sci. USA 109, 12668\u201312673 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59626_CR81","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2337\/db08-0882","volume":"58","author":"APR Sutherland","year":"2009","unstructured":"Sutherland, A. P. R. et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58, 1144\u20131155 (2009).","journal-title":"Diabetes"},{"key":"59626_CR82","first-page":"861920","volume":"2011","author":"R Meazza","year":"2011","unstructured":"Meazza, R., Azzarone, B., Orengo, A. M. & Ferrini, S. Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy. J. Biomed. Biotechnol. 2011, 861920 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"59626_CR83","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nri2580","volume":"9","author":"Y Rochman","year":"2009","unstructured":"Rochman, Y., Spolski, R. & Leonard, W. J. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9, 480\u2013490 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"59626_CR84","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s11892-014-0518-9","volume":"14","author":"P Monti","year":"2014","unstructured":"Monti, P. & Bonifacio, E. Interleukin-7 and type 1 diabetes. Curr. Diab Rep. 14, 518 (2014).","journal-title":"Curr. Diab Rep."},{"key":"59626_CR85","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","volume":"24","author":"F Carrette","year":"2012","unstructured":"Carrette, F. & Surh, C. D. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin. Immunol. 24, 209\u2013217 (2012).","journal-title":"Semin. Immunol."},{"key":"59626_CR86","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11892-016-0731-9","volume":"16","author":"D Vignali","year":"2016","unstructured":"Vignali, D. & Monti, P. Targeting homeostatic T cell proliferation to control beta-cell autoimmunity. Curr. Diab Rep. 16, 40 (2016).","journal-title":"Curr. Diab Rep."},{"key":"59626_CR87","doi-asserted-by":"crossref","unstructured":"Szabo, P. A., Miron, M. & Farber, D. L. Location, location, location: tissue resident memory T cells in mice and humans. Sci. Immunol. 4, eaas9673 (2019).","DOI":"10.1126\/sciimmunol.aas9673"},{"key":"59626_CR88","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibri\u00e1n","year":"2017","unstructured":"Cibri\u00e1n, D. & S\u00e1nchez-Madrid, F. CD69: from activation marker to metabolic gatekeeper. Eur. J. Immunol. 47, 946\u2013953 (2017).","journal-title":"Eur. J. Immunol."},{"key":"59626_CR89","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00125-019-05047-w","volume":"63","author":"LM Jacobsen","year":"2020","unstructured":"Jacobsen, L. M. et al. The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening. Diabetologia 63, 588\u2013596 (2020).","journal-title":"Diabetologia"},{"key":"59626_CR90","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1158\/1078-0432.CCR-16-3192","volume":"23","author":"X Feng","year":"2017","unstructured":"Feng, X. et al. Targeting CD38 suppresses induction and function of T regulatory cells to mitigate immunosuppression in multiple myeloma. Clin. Cancer Res. 23, 4290\u20134300 (2017).","journal-title":"Clin. Cancer Res."},{"key":"59626_CR91","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","volume":"128","author":"J Krejcik","year":"2016","unstructured":"Krejcik, J. et al. Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. Blood 128, 384\u2013394 (2016).","journal-title":"Blood"},{"key":"59626_CR92","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrneph.2017.138","volume":"13","author":"MJ Smith","year":"2017","unstructured":"Smith, M. J., Simmons, K. M. & Cambier, J. C. B cells in type 1 diabetes mellitus and diabetic kidney disease. Nat. Rev. Nephrol. 13, 712\u2013720 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"59626_CR93","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2337\/dc09-0934","volume":"32","author":"T Orban","year":"2009","unstructured":"Orban, T. et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial-type 1. Diab. Care 32, 2269\u20132274 (2009).","journal-title":"Diab. Care"},{"key":"59626_CR94","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12865-022-00505-4","volume":"23","author":"B Li","year":"2022","unstructured":"Li, B. et al. Comprehensive evaluation of the effects of long-term cryopreservation on peripheral blood mononuclear cells using flow cytometry. BMC Immunol. 23, 30 (2022).","journal-title":"BMC Immunol."},{"key":"59626_CR95","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cell.2020.11.035","volume":"184","author":"AS Japp","year":"2021","unstructured":"Japp, A. S. et al. HPAP Consortium, Atkinson, TCR+\/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes. Cell 184, 827\u2013839.e14 (2021).","journal-title":"Cell"},{"key":"59626_CR96","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.xpro.2020.100154","volume":"1","author":"L Kuri-Cervantes","year":"2020","unstructured":"Kuri-Cervantes, L., Pampena, M. B. & Betts, M. R. Phenotypic characterization of SLex+ and CLA+ CD4+ T Cells. STAR Protoc. 1, 100154 (2020).","journal-title":"STAR Protoc."},{"key":"59626_CR97","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"59626_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1603-1","volume":"19","author":"M Stoeckius","year":"2018","unstructured":"Stoeckius, M. et al. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).","journal-title":"Genome Biol."},{"key":"59626_CR99","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41587-021-00870-2","volume":"39","author":"P Melsted","year":"2021","unstructured":"Melsted, P. et al. Modular, efficient and constant-memory single-cell RNA-seq preprocessing. Nat. Biotechnol. 39, 813\u2013818 (2021).","journal-title":"Nat. Biotechnol."},{"key":"59626_CR100","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"59626_CR101","doi-asserted-by":"publisher","first-page":"D1003","DOI":"10.1093\/nar\/gkac888","volume":"51","author":"RL Seal","year":"2023","unstructured":"Seal, R. L. et al. Genenames.org: the HGNC resources in 2023. Nucleic Acids Res. 51, D1003\u2013D1009 (2023).","journal-title":"Nucleic Acids Res."},{"key":"59626_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 9, 559 (2008).","journal-title":"BMC Bioinforma."},{"key":"59626_CR103","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.crmeth.2023.100498","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito, S., Reese, F., Rahimzadeh, N., Miyoshi, E. & Swarup, V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep. Methods 3, 100498 (2023).","journal-title":"Cell Rep. Methods"},{"key":"59626_CR104","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1034\/j.1399-0039.2003.00103.x","volume":"62","author":"W Klitz","year":"2003","unstructured":"Klitz, W. et al. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62, 296\u2013307 (2003).","journal-title":"Tissue Antigens"},{"key":"59626_CR105","unstructured":"Hadley, W. Ggplot2: Elegrant Graphics for Data Analysis (Springer, 2016)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59626-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T08:02:27Z","timestamp":1747555347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59626-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59626"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59626-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.23.590798","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,18]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4621"}}